- Home
- KGEI vs LFCR Comparison
KGEI vs LFCR Comparison
Compare KGEI & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KGEI | LFCR |
|---|---|---|
| Founded | 2008 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.3M | 143.9M |
| IPO Year | 2009 | 1996 |
Fundamental Metrics
Financial Performance| Metric | KGEI | LFCR |
|---|---|---|
| Price | $5.89 | $4.96 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 256.8K | 180.0K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | $32.37 | N/A |
| Revenue Next Year | $4.72 | $5.04 |
| P/E Ratio | $7.94 | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $3.35 | $3.63 |
| 52 Week High | $8.27 | $8.98 |
Technical Indicators
Market Signals| Indicator | KGEI | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 54.62 | 53.48 |
| Support Level | $5.13 | $4.75 |
| Resistance Level | $5.88 | $5.45 |
| Average True Range (ATR) | 0.31 | 0.31 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 52.49 | 61.30 |
Price Performance
Historical ComparisonAbout KGEI Kolibri Global Energy Inc.
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.